InventaBioTech Inc.
company.status.inactiveCIK 1421603fmd_0ER061CMXAGMD3N4SK8KXJEDFYManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2018, 34 periods
Latest annual · FY2017
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
- Free cash flow
- 0
Latest quarter · Q3 FY2018
Millions- Total revenues
- 1
- Gross profit
- 1
- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2014 to FY2017
- -5.8%
- Revenue, 5 yearsFY2012 to FY2017
- -3.8%
- Net income, 5 yearsFY2012 to FY2017
- n/m
InventaBioTech Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Revenue | $157,926 | $178,019 | -11.3% | 10-K 2018-03-16 · proof |
| Operating income | -$472,255 | -$150,353 | 10-K 2018-03-16 · proof | |
| Net income | -$68,497 | -$151,969 | 10-K 2018-03-16 · proof | |
| Cash from operating activities | -$2,048 | $138,590 | -101.5% | 10-K 2018-03-16 · proof |
| Total assets | $809,000 | $742,755 | +8.9% | 10-Q 2018-09-27 · proof |
| Total liabilities | $292,000 | $40,385 | +623% | 10-Q 2018-09-27 · proof |
| Cash and cash equivalents | $235,000 | $685,000 | -65.7% | 10-Q 2018-09-27 · proof |
- What was InventaBioTech Inc.'s revenue in fiscal 2017?
- InventaBioTech Inc. reported revenue of $157,926 for fiscal 2017 (the year ended Dec 31, 2017), against $178,019 the year before (-11.3%). Source: the 10-K filed with the SEC on Mar 16, 2018. SEC
- What was InventaBioTech Inc.'s operating income in fiscal 2017?
- InventaBioTech Inc. reported operating income of -$472,255 for fiscal 2017 (the year ended Dec 31, 2017), against -$150,353 the year before. Source: the 10-K filed with the SEC on Mar 16, 2018. SEC
- What was InventaBioTech Inc.'s net income in fiscal 2017?
- InventaBioTech Inc. reported net income of -$68,497 for fiscal 2017 (the year ended Dec 31, 2017), against -$151,969 the year before. Source: the 10-K filed with the SEC on Mar 16, 2018. SEC
- What was InventaBioTech Inc.'s cash from operating activities in fiscal 2017?
- InventaBioTech Inc. reported cash from operating activities of -$2,048 for fiscal 2017 (the year ended Dec 31, 2017), against $138,590 the year before (-101.5%). Source: the 10-K filed with the SEC on Mar 16, 2018. SEC
- What are InventaBioTech Inc.'s total assets?
- As of Dec 31, 2017, InventaBioTech Inc. reported total assets of $809,000, against $742,755 a year earlier (+8.9%). Source: the 10-Q filed with the SEC on Sep 27, 2018 (restated). SEC
- What are InventaBioTech Inc.'s total liabilities?
- As of Dec 31, 2017, InventaBioTech Inc. reported total liabilities of $292,000, against $40,385 a year earlier (+623%). Source: the 10-Q filed with the SEC on Sep 27, 2018 (restated). SEC
- What are InventaBioTech Inc.'s cash and cash equivalents?
- As of Dec 31, 2017, InventaBioTech Inc. reported cash and cash equivalents of $235,000, against $685,000 a year earlier (-65.7%). Source: the 10-Q filed with the SEC on Sep 27, 2018 (restated). SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1421603&period_type=annual&limit=5"Information only, not investment advice.